Research and analysis

Global high consequence infectious disease events: summary September 2023

Updated 6 August 2024

Interpreting this report

The report provides updates on known, high-consequence infectious disease (HCID) events around the world as monitored by the UK Health Security Agency’s (UKHSA) epidemic intelligence activities.

The report is divided into 2 sections covering all the defined HCID pathogens. The first section contains contact and airborne HCIDs that have been specified for the HCID programme by NHS England. The second section contains additional HCIDs that are important for situational awareness.

Each section contains information on known pathogens and includes descriptions of recent events. If an undiagnosed disease event occurs that could be interpreted as a potential HCID, a third section will be added to the report.

Events found during routine scanning activities that occur in endemic areas will briefly be noted in the report. Active surveillance, other than daily epidemic intelligence activities, of events in endemic areas will not be conducted (for example, actively searching government websites or other sources for data on case numbers).

The target audience for this report is any healthcare professional who may be involved in HCID identification, treatment and management.

Risk rating

Included for each disease is a current risk rating based on the probability of introduction to the UK and potential impact. Past UK experience and the global occurrence of travel-associated cases are also considered. Currently, all diseases are classified into one of 3 categories: Low, Very low and Exceptionally low/negligible.

Incidents of significance of primary HCIDs

Contact HCIDs

Crimean-Congo haemorrhagic fever (CCHF)

Geographical risk areas Endemic in Africa, the Balkans, the Middle East and western and south-central Asia. Cases have also been reported in Russia and Georgia. Spain has previously reported locally acquired cases (first reported in 2016, with the latest case reported in 2022).
Sources and routes of infection • bite from, or crushing of, an infected tick
• contact with the blood, tissues or body fluids of infected humans or animals
UK experience to date Two cases have been reported in individuals who have travelled to the UK from Afghanistan in 2012 and Bulgaria in 2014
Risk rating Low – rarely reported in travellers.
Recent cases or outbreaks Between 1 January and 30 September 2023, a total of 1,115 cases, including 105 deaths (case fatality rate (CFR) of 9.4%) were reported in Afghanistan by the World Health Organization (WHO). Most fatal cases were reported from Kabul (48 deaths) and Balkh (15 deaths) provinces. In 2022, Afghanistan reported 103 confirmed CCHF cases, including 15 deaths.

In Iraq, between 1 January and 10 September 2023 (latest available data), 509 cases of CCHF, including 64 deaths, were reported nationally. On 24 September 2023, media reported that an additional 12 CCHF cases had been registered in the week prior. 

On 9 September 2023, Mauritania’s Ministry of Health notified a confirmed CCHF case in a 23-year-old female from Assaba Region. This is the second confirmed CCHF case reported in Mauritania so far in 2023.

In September 2023, one confirmed CCHF case was reported in Senegal. As of 30 September 2023, 5 confirmed cases, including 1 death, have been reported in 2023 (one each from Dakar, Gossas, Fatick, Louga and Yeumbeul regions).

Ebola virus disease (EVD)

Geographical risk areas Map of countries which have reported EVD cases up to January 2023.
Sources and routes of infection • contact with blood, tissues or body fluids of infected animals, or consumption of raw or undercooked infected animal tissue
• contact with infected human blood or body fluids
UK experience to date Four confirmed cases (one lab-acquired in the UK in 1976, 3 healthcare workers associated with West African epidemic 2014 to 2015).
Risk rating Very low – other than during the West Africa outbreak, exported cases are extremely rare.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Lassa fever

Geographical risk areas Endemic in sub-Saharan West Africa.
Sources and routes of infection • contact with excreta, or materials contaminated with excreta from an infected rodent
• inhalation of aerosols of excreta from an infected rodent
• contact with infected human blood or body fluids
UK experience to date Three travel-related Lassa fever cases reported in 2022. Prior to this, 13 imported Lassa fever cases had been reported since 1971, all in travellers from West Africa.
Risk rating Low – overall, Lassa fever is the most common imported viral haemorrhagic fever (VHF) but importations to the UK are still rare.
Recent cases or outbreaks On 6 September 2023, media reported that 6 cases of Lassa fever, including one death, were detected at Boko hospital, Borgou department, Benin.

In Liberia, from 6 January 2022 to 21 September 2023, a total of 90 confirmed cases of Lassa fever and 27 deaths were reported nationally. This is an increase of one case and death since the last report.

Between 1 January and 17 September 2023, Nigeria reported 1,068 confirmed and 7,352 suspected Lassa fever cases. Among confirmed cases, 181 deaths have been reported (CFR of 16.9%). The number of confirmed cases and deaths reported in 2023 is higher compared to the equivalent 2022 period (857 cases including 169 deaths; CFR of 19.1%), while the CFR remains lower.

Marburg virus disease (MVD)

Geographical risk areas Sporadic outbreaks have previously been reported in Central and Eastern Africa.

A human case of MVD was reported in August 2021 in Guinea; this was the first case to be identified in West Africa. MVD cases were reported in Ghana for the first time in July 2022. MVD outbreaks were reported for the first time in Equatorial Guinea in February 2023 and in Tanzania in March 2023.
Sources and routes of infection • exposure in mines or caves inhabited by Rousettus bat colonies
• contact with infected human blood or body fluids
UK experience to date No reported cases in the UK.
Risk rating Very low – globally, 5 travel-related exported MVD cases have previously been reported in the literature.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Airborne HCIDs

Avian influenza A(H7N9) virus

Geographical risk areas All reported human infections have been acquired in China.
Sources and routes of infection • close contact with infected birds or their environments
• close contact with infected humans (no sustained human-to-human transmission)
UK experience to date No known cases in the UK.
Risk rating Very low (UKHSA risk assessment).
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Avian influenza A(H5N1) virus

Geographical risk areas Human cases have been predominantly reported in South East Asia, but also in Egypt, Iraq, Pakistan, Turkey and Nigeria. Human cases (clade 2.3.4.4b) were reported in Spain and the USA in 2022, and in the UK in 2022 and 2023. The first human cases of avian influenza A(H5N1) (clade 2.3.4.4b) were reported from South America in 2023, from Ecuador and Chile.
Sources and routes of infection • close contact with infected birds or their environments
• close contact with infected humans (no sustained human-to-human transmission)
UK experience to date As of September 2023, 5 detections were reported in the UK, one in 2022 and 4 in 2023.
Risk rating Very low (UKHSA risk assessment).
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Middle East respiratory syndrome (MERS-CoV)

Geographical risk areas The Arabian Peninsula – Yemen, Qatar, Oman, Bahrain, Kuwait, Saudi Arabia and United Arab Emirates.
Sources and routes of infection • airborne particles
• direct contact with contaminated environment
• direct contact with camels or consumption of raw camel milk
UK experience to date Five MERS-CoV cases in total – 3 imported cases (2012, 2013 and 2018), 2 secondary cases in close family members of the case in 2013, 3 deaths.
Risk rating Very low (UKHSA risk assessment).
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Mpox (Clade I only)

Geographical risk areas Central Africa including, Central African Republic, Cameroon, the Democratic Republic of the Congo (DRC), Gabon and Republic of the Congo.
Sources and routes of infection • close contact with an infected animal (in an endemic country) or an infected person
• contact with clothing or linens (such as bedding or towels) used by an infected person
• direct contact with mpox skin lesions or scabs
• coughing or sneezing of an individual with an mpox rash
• consumption of contaminated bushmeat
UK experience to date In June 2022, the Advisory Committee on Dangerous Pathogens (ACDP) recommended that the strain of monkeypox virus (MPXV) largely responsible for the global outbreak (Clade IIb, B.1 lineage) should no longer be classified as an HCID. In January 2023, the ACDP recommended that all Clade II MPXV should no longer be classified as an HCID.

No cases of Clade I mpox have been reported in the UK.

Between 2018 and 2021, 7 cases of mpox were identified in the UK which would no longer be classified as HCID mpox, but were treated as HCID cases at the time: 4 of the cases were imported from Nigeria, 2 cases were household contacts and one case was a healthcare worker involved in the care of an imported case.
Risk rating Very low – no known importations of Clade I mpox into the UK.
Recent cases or outbreaks Sequencing data is rarely available for mpox cases reported from endemic African countries where clade I MPXV is known to circulate.

In September 2023, 5 new confirmed cases (no deaths) were reported from the Republic of the Congo, bringing the total number of cases to 12 reported by WHO from this country in 2023.

In the DRC, 9 new confirmed cases (no deaths) were reported in September 2023, bringing the total number of confirmed cases reported since the start of 2023 to 610, including 2 deaths.

Nipah virus

Geographical risk areas South East Asia, predominantly in Bangladesh and India. Cases have also been reported in Malaysia and Singapore.
Sources and routes of infection • direct or indirect exposure to infected bats
• consumption of contaminated raw date palm sap
• close contact with infected pigs or humans
UK experience to date No known cases in the UK.
Risk rating Exceptionally low/negligible – no travel-related infections in the literature.
Recent cases or outbreaks Between 12 and 15 September 2023, India’s Ministry of Health and Family Welfare reported 6 laboratory-confirmed Nipah virus cases, including 2 deaths, in Kozhikode district, Kerala. The last confirmed case was reported on 15 September 2023. As of 27 September 2023, 1,288 contacts of the confirmed cases had been traced, with no new cases identified. This is the sixth outbreak of Nipah virus in India since 2001.

Pneumonic plague (Yersinia pestis)

Geographical risk areas Predominantly sub-Saharan Africa but also Asia, North Africa, South America, Western USA. Endemic in Madagascar, Peru, and the DRC.
Sources and routes of infection • flea bites
• close contact with infected animals
• close contact with human cases of pneumonic plague
UK experience to date Last outbreak in the UK was in 1918.
Risk rating Exceptionally low/negligible – no known current outbreaks globally.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Severe acute respiratory syndrome (SARS)

Geographical risk areas Currently none. Two historical outbreaks originating from China in 2002 and 2004.
Sources and routes of infection • airborne particles
• direct contact with contaminated environment
UK experience to date Four imported SARS cases related to the 2002 outbreak.
Risk rating Exceptionally low/negligible – no cases have been reported internationally since 2004.
Recent cases or outbreaks No confirmed or suspected human cases reported globally since 2004.

Incidents of significance of additional HCIDs

Argentine haemorrhagic fever (Junin virus)

Geographical risk areas Argentina (central). Endemic to the provinces of Buenos Aires, Córdoba, Santa Fe and La Pampa.
Sources and routes of infection • direct contact with infected rodents
• inhalation of infectious rodent fluids and excreta
• person-to-person transmission has been documented
UK experience to date No known cases in the UK.
Risk rating Exceptionally low/negligible – one travel-related case was identified in Belgium in 2020.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Bolivian haemorrhagic fever (Machupo virus)

Geographical risk areas Bolivia – cases have been identified in the departments of Beni (Mamoré, Iténez and Yucuma provinces) and Cochabamba (Cercado province).
Sources and routes of infection • direct contact with infected rodents
• inhalation of infectious rodent fluids and excreta
• person-to-person transmission has been documented
UK experience to date No known cases in the UK.
Risk rating Exceptionally low/negligible – travel-related cases have never been reported.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Lujo virus disease

Geographical risk areas A single case acquired in Zambia led to a cluster in South Africa in 2008.
Sources and routes of infection • presumed rodent contact (excreta, or materials contaminated with excreta of infected rodent)
• person to person via body fluids
UK experience to date No known cases in the UK.
Risk rating Exceptionally low/negligible – a single travel-related case has been reported. No cases have been reported anywhere since 2008.
Recent cases or outbreaks No confirmed or suspected human cases reported since 2008.

Severe fever with thrombocytopenia syndrome (SFTS)

Geographical risk areas Mainly reported from China (south-eastern), Japan and Korea. Cases have also been reported in Taiwan, Thailand, Myanmar and Vietnam. Serological evidence of SFTS in Pakistan.
Sources and routes of infection • presumed to be tick exposure
• person-to-person transmission described in household and hospital contacts, via contact with blood or bloodstained body fluids
UK experience to date No known cases in the UK.
Risk rating Exceptionally low/negligible – not known to have occurred in travellers.
Recent cases or outbreaks On 20 September 2023, media reported that between 1 January and 20 September 2023, 118 SFTS cases, including 23 deaths, had been reported nationally in South Korea. During the equivalent 2022 period, 129 cases and 22 deaths were reported.

Andes virus (Hantavirus)

Geographical risk areas Chile and southern Argentina.
Sources and routes of infection • rodent contact (excreta, or materials contaminated with excreta from an infected rodent)
• person-to-person transmission described in household and hospital contacts
UK experience to date No known cases in the UK.
Risk rating Very low – rare cases in travellers have been reported.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Avian influenza A(H5N6) virus

Geographical risk areas Mostly China. New strain reported in Greece in March 2017, and subsequently found in Western Europe in birds.
Sources and routes of infection Close contact with infected birds or their environments.
UK experience to date No known cases in the UK.
Risk rating Very low – not known to have occurred in travellers (UKHSA risk assessment).
Recent cases or outbreaks In China, a fatal human case of avian influenza A(H5N6) was reported in Chongqing Municipality during September 2023. The case was a 68-year-old male living in Chongqing, Sichuan Province, who had exposure to live domestic poultry before the onset of symptoms on 5 August 2023. From 2014 to 28 September 2023, 87 human cases of avian influenza A(H5N6) were reported by mainland China health authorities.

Avian influenza A(H7N7) virus

Geographical risk areas Sporadic occurrence in birds across mainland Europe and the UK. A human case was reported in Ireland in 1996, 89 cases were reported in the Netherlands in 2003, and 3 human cases were reported in Italy in 2013.
Sources and routes of infection • close contact with infected birds or their environments
• close contact with infected humans (no sustained human-to-human transmission reported)
UK experience to date No known cases in the UK.
Risk rating Very low – human cases are rare, and severe disease even rarer.
Recent cases or outbreaks No confirmed or suspected human cases were reported in September 2023.

Authors of this report

Emerging Infections and Zoonoses Team, UKHSA